Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions-Reference-Cited by-同舟云学术

Safety and efficacy of P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary interventions

Published:2020-11-30 Issue:1 Volume:20 Page:9-21
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Galli Mattia¹²^ORCID,Capodanno Davide³^ORCID,Andreotti Felicita¹,Crea Filippo¹,Angiolillo Dominick J²^ORCID

Affiliation:

1. Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy

2. Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States

3. Division of Cardiology, C.A.S.T., P.O. “G. Rodolico,” Azienda Ospedaliero Universitaria “Policlinico-Vittorio Emanuele”, University of Catania, Catania, Italy

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1850691

Reference96 articles.

1. ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy

2. 2018 ESC/EACTS Guidelines on myocardial revascularization

3. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

5. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interindividual variability in platelet reactivity among individuals with or without antiplatelet therapy: results from a large tertiary care hospital;Journal of Thrombosis and Thrombolysis;2024-09-06

2. Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies;Expert Opinion on Therapeutic Targets;2024-02

3. Antithrombotic Treatment in Coronary Artery Disease;Current Pharmaceutical Design;2023-10

4. How is pharmacogenetics changing clinical trial design for percutaneous coronary intervention?;Expert Review of Clinical Pharmacology;2023-04-17

5. De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy?;European Journal of Internal Medicine;2023-04